BSE filing, NSE: FRONTCORP. Summary written from the filing by ALFA Finder's alert engine.
Frontline Corporation Ltd: key numbers
- Share price
- ₹36.18
- Market cap
- ₹18.09 Cr
- Revenue (annual)
- ₹118.3 Cr
- Net profit (annual)
- ₹2.41 Cr
- P/E (TTM)
- 6.9×Sector 31.1×
- Promoter holding
- 47.19%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Frontline Corporation Ltd
All →Frontline Corporation Board Meeting Date
Frontline Corporation Ltd has scheduled a Board meeting for November 5, 2026. The agenda includes consideration of results for the quarter ended September 30, 2026.
Frontline Corporation Other Announcement
Frontline Corporation Limited has filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31(1)(b).
Frontline Corporation Annual General Meeting
Frontline Corporation Limited held its 37th Annual General Meeting. The company adopted financial statements and re-appointed directors by the requisite majority.
Frontline Corporation Annual General Meeting
Frontline Corporation Limited has scheduled its 37th Annual General Meeting for September 22, 2026. Key agenda items include adopting financial statements and re-appointing two directors.
Frontline Corporation Annual Report
Frontline Corporation Limited released its 37th Annual Report for the financial year 2025-2026. The Annual General Meeting is scheduled for September 22, 2026, via video conferencing.
Frontline Corporation Q1 FY27 Results: Net Profit ₹0.8 Cr, Up 33.3% YoY
Frontline Corporation Ltd reported revenue from operations of ₹28.3 Cr (-10.2% YoY) and net profit of ₹0.8 Cr (+33.3% YoY) for Q1 FY27.
- Key figure
- Net profit ₹0.8 Cr · +33.3% YoY
Other price movement clarification announcements
All →Aegis Logistics Price Movement Clarification
Aegis Logistics clarified to BSE that the unusual volume surge is purely market-driven with no undisclosed information. The company confirmed compliance with Reg 30 LODR.
Marsons Price Movement Clarification
Marsons Ltd. replied to an exchange price-movement query stating no undisclosed information exists. The company affirmed compliance with LODR and no future disclosure is pending.
Dr. Reddy's Laboratories Price Movement Clarification
Dr. Reddy's confirms FDA tentative approval for its lenacapavir HIV shot. The company states the news is not material and has no material impact.
Yaap Digital Price Movement Clarification
Yaap Digital told NSE no undisclosed event explains its recent share price movement. The Company confirmed all disclosures are timely and the movement is market-driven.
Quality RO Industries Price Movement Clarification
Quality RO Industries clarified BSE's surveillance query on share price movement, stating it was purely market-driven with no undisclosed material information.
Mahanagar Telephone Nigam Price Movement Clarification
MTNL responded to an NSE surveillance query on a volume spurt, stating no undisclosed material information exists. The share price movement is attributed to market conditions alone.